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CHAPTER I 
 
INTRODUCTION 
 
Significance of telomeres and telomerase 
 Telomeres are unique repetitive sequences at the ends of linear eukaryotic 
chromosomes.  The strand running 5´ to 3´ (centromere to telomere) is TG-rich and ends 
in a 3´ overhang (reviewed in Ref. 1).  Telomeric sequences provide binding sites for 
various proteins on both the double- and single-stranded DNA1-4.  The main function of 
these protein/DNA complexes is to maintain genomic stability of the cell by capping 
chromosome ends, thereby protecting them from nucleolytic degradation, recognition as 
double-strand breaks, and end-to-end fusions.  If the capping function of telomeres is lost, 
chromosome ends fuse, forming dicentric chromosomes that can be broken at random 
during anaphase, which result in gross genomic instability and usually cell death1,5-7.  If 
checkpoint mechanisms are bypassed, this breakage-fusion-breakage cycle can continue, 
causing wide-spread, large-scale mutagenesis in an event known as crisis.  Rarely, cells 
may activate a telomere maintenance pathway in this stage, halting the breakage-fusion-
breakage cycle and establishing a new stable telomere length homeostasis (reviewed in 
Refs. 1,8; Figure 1).  This event is just one hallmark of tumorigenesis.  However, since 
telomere maintenance allows for perpetual self-renewal, these cells can divide 
indefinitely and need only to acquire mutations in certain other pathways to become 
cancerous1,9-11. 
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 Impaired telomere maintenance has also been associated with other disease states, 
the most common of which is dyskeratosis congenita1,12.  This condition results from a 
number of inherited mutations13,14, displays disease anticipation15,16, and includes 
symptoms of nail dystrophy, abnormal skin pigmentation, premature aging, aplastic 
anemia, and increased susceptibility to cancer1,12.  In aplastic anemia, proper telomere 
maintenance is disrupted in bone marrow stem cells, implicating telomeres in the aging 
process. 
 Interestingly, telomerase, the enzyme responsible for maintaining telomere length, 
is expressed in germ cells at relatively high levels throughout the human lifespan, 
ensuring that offspring are born with telomeres of sufficient initial length17,18.  In stem 
cells, telomerase expression decreases over a lifetime, leading to limited self-renewal of 
stem cells and by extension, tissues that require replacement over time6.  Somatic cells, in 
contrast, do not express telomerase, and telomeres in these cells shorten at a relatively 
fast rate until reaching the point known as the Hayflick limit when cell cycle arrest is 
triggered9,19-21.  Cells that continue to divide past this point through the loss of checkpoint 
control enter crisis, described above (reviewed in Refs. 1,8; Figure 1).  Normally, at the 
time of cell cycle arrest or certainly during crisis, old somatic cells are removed and 
replaced.  It is the reduced renewal potential of stem cells that limits the body’s ability to 
replace somatic cells, which has been linked to aging phenotypes1. 
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Figure 1.  Telomere length in human cells.  Germ cells and stem cells express 
telomerase and maintain relatively stable telomere length over the human lifespan (red).  
Somatic cells lack telomerase, so their telomeres shorten with cell divisions (blue).  At 
the Hayflick limit, cellular machinery senses short telomeres and triggers cell cycle 
arrest.  If cells bypass this arrest, telomeres continue shortening until the capping function 
is lost in crisis.  Rarely, activation of a telomere maintenance pathway permits cells to 
exit crisis.  If telomere maintenance is achieved by telomerase activity, telomeres are 
usually maintained at a short but stable length (Modified from Bryan and Cech, 1999) 8 
 
 
 Considering the apparent importance of telomere maintenance to avoid genomic 
instability and disease states, significant research effort has been directed at 
understanding all aspects of telomere biology, from describing the telomere itself to 
telomerase function and regulation (reviewed in Ref. 1).  Telomeres were originally 
described in the first half of the 20th century when Drs. Hermann Muller and Barbara 
McClintock independently demonstrated, in flies and maize, respectively, that the ends of 
linear chromosomes are unique regions of the chromosome, resistant to fusion and 
necessary for cell viability22,23.  Muller termed the free ends of the chromosome 
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“telomeres” in 193822.  Years later, as more information was gleaned about the DNA 
double helix, speculations about telomere replication arose.  In the early 1970s, Drs. 
Alexey Olovnikov and James Watson independently posed the end replication problem, a 
phenomenon describing the inability of the canonical DNA replication machinery to fully 
replicate the ends of linear chromosomes24,25.   
 Classical DNA polymerases require a free 3´ hydroxyl group as a substrate for 
nucleotide addition, so an RNA primer is laid down to initiate DNA replication in a 5´ to 
3´ direction.  Following completion of replication, this RNA primer is removed from the 
daughter strand of lagging strand synthesis, recreating the single-stranded 3´ overhang 
required at the chromosome terminus.  Leading strand synthesis results in a blunt-ended 
product that is processed by resection of the 5´ strand to regenerate the 3´ overhang 
(reviewed in Ref. 26; Figure 2).  The double- and single-stranded portions of the telomere 
are then bound by various proteins to fulfill the protective capping function at 
chromosome ends1-4.  However, processing of the 5´ strand results in degradation of 
terminal sequences and telomere shortening.  Unchecked, this gradual shortening 
continues with successive rounds of DNA replication and leads to loss of telomeric 
sequences.  Fortunately, the majority of the time, the cellular machinery that senses short 
telomeres inhibits further cell cycle progression, so genetic information is preserved.  
Additionally, to counteract this end replication problem, cells express the enzyme 
telomerase.  Telomerase is a ribonucleoprotein (RNP) with a reverse transcriptase 
component that utilizes the internal RNA moiety as a template for nucleotide addition to 
the single-stranded 3´ overhang at chromosome termini1. 
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Figure 2.  The end replication problem leads to loss of DNA sequence from the 
leading strand template and chromosome end shortening with successive rounds of 
DNA replication.  An RNA primer is laid down to initiate DNA replication in a 5´ to 3´ 
direction.  At the chromosome ends, the leading strand (red) and newly synthesized 
complement (pink) form blunt-ended double-stranded DNA, whereas the lagging strand 
(dark blue) and its complement (light blue) consist of template DNA and an RNA primer.  
To re-establish the necessary 3´ overhang, the 5´ end of the original leading strand (red) 
is resected and the RNA primer is removed from the lagging strand complement (light 
blue).  These processing events result in shortened templates for leading strand synthesis 
in the following round of DNA replication.  (Modified from Osterhage and Friedman, 
2009)26 
 
 
Telomerase in Saccharomyces cerevisiae 
 In S. cerevisiae, the telomerase RNP minimally consists of the TLC1 RNA and 
three Ever Shorter Telomere (EST) proteins (Figure 3) 27-29.  TLC1 contains the template 
region for nucleotide addition by the reverse transcriptase Est2p27,30,31.  TLC1 and Est2p 
are the only components required for in vitro telomerase activity and comprise the 
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catalytic core of the enzyme32.  Though not required for in vitro activity, the Est1 and 
Est3 proteins are necessary for in vivo telomere maintenance and are thought to serve 
regulatory functions in the cell32-35.  Despite having been discovered over two decades 
ago, there are still many questions concerning precise assembly and function of each 
component of the yeast telomerase complex. 
 
 
 
 
Figure 3.  Telomerase complex in Saccharomyces cerevisiae.  The reverse transcriptase 
subunit Est2p utilizes the template region of the TLC1 RNA (boxed) to add telomeric 
repeats to chromosomal termini (indicated by arrow).  Est1p and Est3p are regulatory 
proteins necessary for in vivo telomere maintenance but dispensable for in vitro enzyme 
activity.  Est1p recruits telomerase to the telomere via its interaction with the single-
stranded DNA-binding protein Cdc13.  (Modified from Smogorzewska and de Lange, 
2004)2 
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 The EST1 gene was identified in a screen for mutant strains that display telomere 
shortening over time, coincident with reduced and variable growth rates, moderate 
temperature sensitivity, and increased chromosome loss and cell death28.  These 
characteristics comprise the EST (Ever Shorter Telomere) phenotype that was used in a 
later screen to identify EST2, EST3, and EST429.  The est4-1 allele was later determined 
to be an allele of CDC13, cdc13-2, disrupted for promoting telomerase access to the 
telomere36 (separable from Cdc13p’s essential DNA binding-dependent end protection 
function)37.  Since Est1p was the first component of yeast telomerase identified, it has 
been extensively studied over the years.  Recombinant Est1p has been shown to weakly 
bind G-rich oligonucleotides33,38,39.  This activity requires a free 3´ end, is sequence-
specific, and resides between amino acids 435 and 565 of the protein38.  Est1p also binds 
a bulged stem loop of the TLC1 RNA in the absence of Est2p or Est3p via an RNA 
recognition motif between amino acids 456 and 51533,40-43.  Est1p promotes single-
stranded, guanine-rich DNA to form higher order G quadruplex (G quartet) structures in 
vitro and can unwind DNA/RNA heteroduplexes; an EF hand-like motif between amino 
acids 494 and 554 of the protein is important for these activities39.  Addition of 
recombinant Est1p stimulates in vitro telomerase activity independent of its ability to 
bind TLC1 or DNA but dependent upon assembly of the holoenzyme44.  Est1p has also 
been shown to interact with other non-telomerase proteins, including the Rfa2p 
component of Replication Protein A (RPA)45 and Ies3p of the INO80 chromatin 
remodeling complex46, which may serve regulatory functions at the telomere.  The 
essential function of Est1p appears to be recruitment of the telomerase holoenzyme to the 
telomere terminus via a direct protein-protein interaction with the single-stranded 
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telomeric DNA-binding protein Cdc1336,47-50.  This interaction is also needed to bring 
telomerase to double-stranded breaks for healing by de novo telomere addition51.  Est1p’s 
telomerase recruitment function can be bypassed by artificially bringing the enzyme to 
the telomere through direct fusion of Cdc13p and Est2p48.  When the Cdc13p-Est2p 
fusion is expressed in an EST1 strain, telomeres over-elongate with respect to wild-type 
telomeres.  Remarkably, expression of Cdc13p-Est2p in an est1∆ strain rescues telomere 
maintenance, supporting the hypothesis that Est1p is required for the recruitment of 
telomerase to the chromosome end.  However, telomere over-elongation no longer occurs 
in the absence of Est1p, suggesting that Est1p may contribute an additional function 
required for robust telomerase activity48. 
 In 2002, a study of est1 mutants created by scanning alanine block mutation 
revealed several classes of est1 alleles52.  The first class caused telomere shortening or 
senescence, but supported telomere over-elongation in the presence of a Cdc13p-Est2p 
fusion.  This class most likely affects the telomerase recruitment function of Est1p.  
Another class displayed reduced association with telomerase, and some of those mutants 
fail to localize correctly to the nucleus (C. Hawkins and K. Friedman, in preparation).  
One class of mutants, including the est1-Δ19 allele, was concluded to be disrupted for an 
additional, unknown function of Est1p.  These mutants have similar telomere length and 
growth defects as the first group of mutants but do not display telomere over-elongation 
in the presence of the Est2-Cdc13 fusion protein.  These data hint at another important 
role of Est1p not rescued by artificially tethering telomerase to the telomere, possibly an 
activation function.  Data from in vitro studies using Candida albicans showed that EST1 
was important for initiation of telomerase activity and elongation of primers53, supporting 
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an activation function of the Est1 protein.  Interestingly, apart from the conserved 
tetratricopepetide repeat (TPR) domain at the N terminus of the protein35,54,55, all of these 
proposed functions map to fewer than two hundred of Est1p’s 699 amino acids (Figure 
4).  The regions specified for different protein functions greatly overlap in the context of 
the amino acid sequence and add a significant layer of complexity as the field tries to 
identify separation-of-function alleles of EST1 that each affects only one of its numerous 
functions in the cell.  
 
 
 
Figure 4.  Domain map of Est1p suggests that a small region within the C terminus 
of the protein is involved in several biochemical activities.  Shown are the DNA-
binding domain (red): residues 435-56538; RNA recognition motif (blue): residues 456-
51533; tetratricopeptide repeat (TPR) domain (orange; dashed region most conserved): 
residues 1-30035,54; est1-Δ19 and est1-42 (pink): residues 499-518 (deleted to create est1-
Δ19) and 287, 290, 291, 292 (mutated to alanine to create est1-42)52; EF hand-like motif 
(green): residues 494-55439. 
 
 
 The TLC1 RNA is approximately 1.3 kilobases in size, with the template for 
telomere elongation forming a single-stranded region surrounded by multiple stem-loop 
structures27,56.  Est2p binds TLC1 outside the 3´ and 5´ template boundaries for synthesis 
of telomeric sequence56.  Like other yeast telomerase RNAs, TLC1 contains several 
regions necessary for proper RNP assembly and structural stability outside the template 
sequence57.  A conserved bulged stem loop from nucleotides 535 to 707 is required for 
Est1p association with the RNA, which is independent of the Est2p-TLC1 interaction41,42.  
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Another stem loop is necessary for binding of the Ku70/80 heterodimer58, and a single-
stranded portion of the RNA is bound by the Sm proteins59.  Data examining 
modifications to the placement of TLC1 structural elements indicate that this RNA 
molecule is a flexible scaffold for protein subunit binding; the long stem-loop structures 
can be swapped in position relative to the template while still retaining function56.  
Additionally, nearly two-thirds of this large RNA molecule are dispensable in vivo and in 
vitro50.  
Est2 is a 102 kDa protein with a conserved reverse transcriptase (RT) domain and 
less highly conserved extensions at both the N and C termini30,31,61,62.  The RT domain 
contains the essential catalytic activity of Est2p30,31, whereas the C-terminal extension is 
mostly dispensable in yeast (although it does contribute to normal levels of activity)63.  
The N-terminal extension (NTE), specific to telomerase reverse transcriptases, is 
important for interacting with the RNA component and the DNA substrate, as well as 
regulating the catalytic activity of the protein61,63-69.  The NTE contains conserved motifs 
originally termed Regions I, II, and III63.  Region I, the most N-terminal of these motifs, 
is now called the Telomerase Essential N-terminus (TEN) domain and has been 
implicated in protein-protein interactions70,71.  There are also data suggesting that Est2p 
may serve a protective function by capping telomeres during part of the cell cycle35,72,73. 
Until very recently, little was known about Est3p.  EST3 was cloned by 
complementation and found that the functional, 181-amino acid gene product is produced 
by a stimulated translational frameshift43,74,75.  Other data have suggested that 
recombinant Est3p dimerizes in vitro, and this activity may be important for in vivo 
telomere maintenance76.  However, mutants compromised for dimerization have not been 
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thoroughly examined for disruption of more recently proposed roles of the Est3 protein, 
and phenotypes from this study may be attributable to protein misfolding.  In the past 
year, Est3p has been shown to associate with both Est2p and Est1p in vitro, as well as 
stimulate in vitro primer extension by telomerase77,78. 
 
Assembly of the yeast telomerase complex/holoenzyme 
Telomerase activity is regulated throughout the cell cycle.  Telomere elongation is 
restricted to late S and G2 phases79,80 due in part to the temporal association of telomerase 
with the telomere, a phenomenon that has been extensively detailed by the Zakian lab 
using chromatin-immunoprecipitation (ChIP)72,81,82.  To summarize, in G1 phase, Est2p 
and TLC1 are associated with the telomere via the direct interaction between the  
double-stranded DNA-binding protein heterodimer Ku70/80 and TLC1 RNA58,72,81,83.  As 
the cycle continues, Est2p and TLC1 association decreases but peaks again in late S 
phase, coincident with the time at which telomeres are elongated72,79,80.  Cdc13p binding 
also increases in S phase, when the single-stranded 3´ overhang is longest72,84.  Est1p’s 
temporal association with the telomere is dictated by the cell cycle-dependent regulation 
of its protein levels.  In G1 phase, Est1p levels are very low due to proteasome-dependent 
degradation of the protein.  As the cell cycle progresses into S phase, Est1 protein levels 
increase, allowing for association with the telomere and telomerase core85.  Est3p 
telomere association generally follows the binding profile of Est1p, but is detectable to a 
slight degree in G1 phase78.  The manner in which Est3p assembles into the telomerase 
complex is currently a topic of debate in the field, one that I have chosen to address from 
the standpoint of the Est1 protein and how Est1p and Est3p interact. 
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The Lundblad group has published several experiments suggesting that Est3p can 
associate with the holoenzyme independently of Est1p.  In each case, Est3p assembly 
with telomerase was assessed by its ability to co-immunoprecipitate (co-IP) the TLC1 
RNA.  Est3p co-immunoprecipitated TLC1 in the absence of Est1p but was unable to co-
IP the RNA when EST2 was deleted from the strain34,43.  This association was also tested 
with different alleles of TLC1.  Est2p cannot bind tlc1-59, while Est1p retains its ability 
to associate with this mutant RNA.  In contrast, the tlc1-47 and tlc1-Δ535-770 alleles 
disrupt the Est1p-binding portion of the RNA, but interaction with Est2p is retained.  
Like Est2p, the Est3 protein could not co-IP the tlc1-59 mutant.  In contrast, Est3p 
retained association with tlc1-47 and tlc1-Δ535-770 even though Est1p did not34.  
However, these results may represent background binding instead of a specific 
interaction.  These data support the conclusion that Est3p assembly with the telomerase 
complex is dependent upon the Est2 protein but independent of Est1p.  
Data from the Friedman lab suggest that Est1p is both necessary and sufficient for 
Est3p to associate with telomerase85.  First, Est2p’s ability to co-immunoprecipitate Est3p 
is drastically reduced in an est1Δ strain and in G1-arrested cells, when Est1 protein levels 
are substantially reduced.  Second, Est3p demonstrates greatly reduced binding with the 
tlc1-Δ535-770 RNA, an allele lacking the stem necessary for Est1p to associate with 
TLC1.  The source of differences in results from those obtained by the Lundblad lab is 
unclear, though contradictions may be attributable to experimental design, including 
differences in protein tags, stringency and efficiency of immunoprecipitation, and use of 
certain controls.  Finally, the association between Est2p and Est3p is greatly increased 
when Est1 protein is over-expressed or stabilized in G1 phase by addition of the 
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proteasome inhibitor MG132.  Supporting the notion that these proteins do interact in 
vivo, a recent study has shown that Est1p and Est3p interact directly in vitro78.   
One way to reconcile these results is to suggest that Est1p is not absolutely 
essential for Est3p to assemble with telomerase.  Indeed, in experiments reported by the 
Friedman lab, Est3p retains a small amount of binding (7%) to the tlc1-Δ535-770 RNA85; 
and Est3p has been shown to directly interact with Est2p77.  Each of these results 
indicates that Est3p can associate with telomerase without Est1p, though its assembly is 
severely reduced in the absence of Est1p in vivo.  Therefore, I hypothesize that Est1p 
stimulates the recruitment of Est3p to the telomerase complex.  In the hopes of 
potentially resolving this question in the field, I proposed to identify the residues in Est1p 
responsible for this stimulatory function using a combination of in vivo and in vitro 
analyses and genetic screens.  To date, numerous tools have been developed to map these 
residues, and preliminary results are presented in this thesis. 
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CHAPTER II  
 
MATERIALS AND METHODS 
 
 Primer sequences are listed in Table 1, yeast strains in Table 2, and plasmids in 
Table 3.  Restriction enzymes were obtained from New England Biolabs (NEB). 
 
Plasmids for over-expressing alleles of EST1 
Plasmid pKF600 is the over-expression vector used for the in vivo assembly assay 
and details of its construction can be found in the Appendix.  Briefly, GALp-HA3-EST1 
was cloned from pRS423 (2µm HIS3) into pRS425 (2µm LEU2).  The EST1 open 
reading frame is flanked by an N-terminal BamHI site and C-terminal SphI site for 
cloning of previously constructed C-terminal deletion mutants (A. Sathiyakumar) from 
pRS423 into pKF600.  These mutants included EST1 CΔ100, EST1 CΔ115, EST1 CΔ136, 
EST1 CΔ150, EST1 CΔ200, and EST1 CΔ250.  EST1 CΔ161 and EST1 CΔ179 were 
amplified from pKF600 with 242bamhIfor paired with EST1del161 and EST1del179, 
respectively, and cloned into the BamHI and SphI sites of pKF600.  The est1-Δ19 allele 
was cloned from pVL1633 (2µm TRP1) into pKF600 using restriction sites NdeI and 
NruI because the deletion in the est1-Δ19 allele was marked with a BamHI site. 
 
Plasmids for screening alleles of EST1 
Plasmids pKF610 and pKF611 were created as follows.  pRS416 EST1 and 
pRS416 HA3-EST1 (CEN URA3) were digested with KpnI, SacI, and AlwNI, and the 
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resulting 3.1 kilobase (kb) and 3.4 kb bands, respectively, were cloned into the KpnI and 
SacI restriction sites in pRS315 (CEN LEU2).  To remove an additional BamHI site in the 
multiple cloning site, pRS315 EST1 and pRS315 HA3-EST1 were digested with PstI and 
XbaI, which flank the extra BamHI site.  The ends were blunted by T4 DNA polymerase 
(NEB) and ligated, resulting in the final plasmid products.  Both of these plasmids can be 
used for screening alleles of EST1, but pKF611 contains an N-terminal HA3 tag for 
immunoprecipitation of Est1p as needed.  The est1-Δ19 allele was cloned from pKF600 
est1-Δ19 into pRS315 EST1 and pRS315 HA3-EST1 using BspEI restriction sites.   
 
Yeast strains for screening alleles of EST1* 
 All gene replacements were performed by transforming specified constructs into 
the appropriate strain by a standard lithium acetate protocol.   
 
Integrating the Est2-Est3 fusion protein 
EST2-G8-EST3 was amplified from the pKF428 fusion plasmid (2µm TRP1) with 
the Xba2 Rev and Est3 Fusion Rev primer pair.  The NATR drug resistance marker was 
amplified from pFA6a NAT-MX6 with primers Fusion NAT For and NAT Est2 Rev.  
These products were used as template to create a single PCR product using outside 
primers Xba2 Rev and NAT Est2 Rev.  The final EST2- G8-EST3 NATR product was 
transformed into the EST2 locus of YKF122 + pKF431 and YKF122 + pKF441, creating 
YKF122 fusion Short and YKF122 fusion Long, respectively (C. Wiser and S. 
Lawrence).   
                                                
* Work from this section was contributed by graduate rotation students as indicated in the text: Caroline 
Wiser, Stacey Lawrence, Derrick Cumberbatch. 
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Integrating the TEF promoter 
The plasmid pKF408 trunc contains a C-terminally truncated version of EST2 that 
was created to destroy the SpeI site within the C terminus of the EST2 gene, leaving only 
the SpeI site in the promoter region for integration of the plasmid into the genome.  
pKF408 (integrating vector URA3 EST2) was partially digested with SpeI; the linear 
product was digested to completion with XbaI; and the resulting ends were ligated 
together, creating pKF408 trunc (S. Lawrence).  A PCR product containing the TEF 
promoter and the first 12 amino acids of Est2p was created using pKF426 TEF as 
template and the primer pair of Est2 TEF For and Est2 TEF Rev (C. Wiser).  This 
product was cloned into pKF408 trunc using the restriction enzymes SpeI and HindIII to 
create pKF408 trunc TEF.  The sequence of the insert was confirmed by sequencing with 
the M13R universal primer.  pKF408 trunc TEF was linearized with SpeI and integrated 
into YKF122 fusion Short and YKF122 fusion Long (S. Lawrence and D. Cumberbatch). 
Two-step integration of the TEF promoter was confirmed by Southern analysis.  
Genomic DNA was digested with HinfI and separated by gel electrophoresis on a 0.8% 
LE agarose (Lonza) gel with 0.003% ethidium bromide run at 80V for 6 hours.  Primers 
H primer For and 3 rev were used to amplify an ~500 base pair (bp) portion of the N 
terminus of EST2, which was randomly-labeled to probe the membrane as previously 
described70.  The endogenous EST2 promoter yields a band at ~900 bp while the TEF 
promoter at the EST2 locus yields a band of 1.2 kb. 
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Creating an est1Δest2Δest3Δ strain 
 To create the est triple mutant strain, pKF428 fusion replaced the pKF444 
plasmid in YKF122 (est3::KANR) est2::HYGR + pKF444 EST3-EST2.  The endogenous 
EST1 gene was replaced with NATR drug resistance amplified from pFA6a NAT-MX6 
using primers EST1 TRP For (OP9806) and EST1 KO Rev2.  YKF122 est2::HYGR 
est1::NATR + pKF428 fusion was then complemented with pRS416 EST1, resulting the 
strain named 1,2,3Δ + 428 fus + 416 E1. 
 
Increasing the number of HA tags on Est3p 
 
Plasmid construction 
 EST3-HA3 with a unique KpnI restriction site between EST3 and the triple 
hemagglutinin tag was cloned from pKF442 (CEN URA3) into pRS306 (integrating 
vector URA3) using PvuII sites flanking the multiple cloning site of each vector.  The 
oligos TopHA-Sfo-HA and BotHA-Sfo-HA were annealed and treated with T4 
polynucleotide kinase (NEB).  The double-stranded product of these reactions contains a 
KpnI restriction site used to clone the HA2 construct into pRS306 EST3-HA3 one or more 
at a time.  pRS306 EST3-HA7 was the result of inserting two HA2 constructs in the same 
orientation, into which another HA2 construct was cloned, to create the final plasmid 
pRS306 EST3-HA9.  The sequence of EST3-HA9 was confirmed with the Est3R primer 
(OP6589) to ensure that the EST3 open reading frame (ORF) was frameshift-corrected for 
production of the full-length protein and that the nine hemagglutinin tags were all the 
correct sequence and orientation.  Using PvuII restriction sites, EST3-HA9 was cloned 
 18 
into the pRS416 vector (2µm URA3).  The NATR drug resistance marker was amplified 
from pFA6a NAT-MX6 with the XbaI F1 and XbaI R2 primer pair and then cloned into 
pRS416 EST3-HA9 using XbaI to make pRS416 EST3-HA9 NATR. 
 
Strain construction 
The bar1::KANR construct was amplified from genomic DNA isolated from 
AVL78 bar1::KANR using the primer pair Bar1 For (BAR2529) and Bar1 Rev 
(BAR2530) and transformed into AVL78 Myc9-EST2 creating AVL78 Myc9-EST2 
bar1::KANR.  pRS416 EST3-HA9 was digested with EcoRV and NdeI.  The EST3-HA9 
NATR portion was purified and transformed into AVL78 bar1::KANR and AVL78 Myc9-
EST2 bar1::KANR to make AVL78 EST3-HA9 bar1::KANR and AVL78 Myc9-EST2 
EST3-HA9 bar1::KANR. 
 
Complementation analysis 
 Functional complementation of EST3-HA9 was tested in YKF122 (est3::KANR).  
Loss of the complementing pKF441 plasmid was selected on 5-fluoroorotic acid plates, 
and pRS416 EST3-HA9 was subsequently transformed using the standard lithium acetate 
method.  Single colonies were passaged three times on media lacking uracil.  Cell 
viability was assessed visually, and telomere length was determined by Southern blot as 
previously described70,77.  Here, XhoI was used to digest genomic DNA, which was then 
separated on a 1.2% LE agarose (Lonza) gel run at 80V for 15.5 hours.  Telomeres were 
detected with a randomly-labeled telomeric probe.  
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Immunoprecipitation and Western analysis 
 500mL or 1L cultures containing pKF600-bearing alleles of EST1 were grown to 
an OD600 ~0.5 in 2% (w/v) raffinose media lacking leucine.  Cells were arrested by 
addition of 1mM alpha factor (Zymo Research) for 3-4hrs, and cell morphology assessed 
by microscopy.  At OD600 ~0.8, galactose was added to a final concentration of 0.2% for 
1hr.  Whole cell extract was prepared by glass bead lysis as previously described70,85.  
500µL of protein extract were normalized to 20mg/mL and incubated with 20µL c-myc 
rabbit polyclonal antibody (A-14, Santa Cruz Biotechnology) at 4ºC for 1hr before 
addition of 60µL Protein G sepharose beads (GE Healthcare) prewashed four times with 
equilibration buffer 1 (10 mM Tris-HCl at pH 8, 1 mM MgCl2, 10% glycerol) and once 
with equilibration buffer 2 [10 mM Tris-HCl at pH 8, 1 mM MgCl2, 10% glycerol, 
200mM NaCl, 0.05% Tween-20, RNasin (1:1,000 dilution; Promega)].  Samples were 
incubated with beads for 4hrs at 4ºC and then washed 5 times for 5 minutes with 0.5mL 
wash buffer 1 (10 mM Tris-HCl at pH 8, 1 mM MgCl2, 10% glycerol, 200mM NaCl, 
0.05% Tween-20) and once for 10 minutes with 0.5mL wash buffer 2 [10 mM Tris-HCl 
at pH 8, 1 mM MgCl2, 10% glycerol, 50mM NaCl, RNasin (1:1,000 dilution; Promega)].  
Washes with buffer 1 were performed such that 100µL of supernatant was left when 
pipetting off waste.  Remaining beads were resuspended in 60µL of buffer 2, and 25µL 
were aliquotted for Western blotting and stored at -80˚C.  For electrophoresis, the 
supernatant was removed from immunoprecipitation samples, and the beads mixed with 
2X Laemmli loading buffer (125 mm Tris-HCl at pH 6.8, 4% SDS, 0.05% bromophenol 
blue, 20% glycerol, 5% β-mercaptoethanol).  Samples were mixed gently two to three 
times while incubated at 100°C for 4min.  The supernatant was immediately loaded on a 
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10% to 12% step gradient gel for separation by SDS-PAGE.  Proteins were transferred to 
Hybond P membrane (GE Healthcare).  The membrane was blocked with 5% 
milk/phosphate buffered saline at pH 7.4 with 0.05% Tween-20 (PBS-T) followed by 
incubation at 4ºC overnight with primary antibodies: murine monoclonal HA.11 (1:500 
dilution; Covance) and murine monoclonal Myc Ab-1 (1:250 dilution; OP10L, EMD 
Biosciences) in 5% milk/PBS-T.  Secondary antibody was peroxidase-conjugated goat 
anti-mouse (Chemicon) used at a 1:10,000 dilution in 5% milk/PBS.  ECL plus Western 
Blotting Detection system (GE Healthcare) was used for detection. 
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Table 1.  Oligonucleotide primers 
 
 
 
Primer name Primer sequence 5´-3´ 
242 bamHI for CCAAGCTTAAAAATGGGATCCTAATGGATAACGAAG 
EST1del161 GAGTGCATGCTCATGGAGAAAGCATCTTAGTCAATG 
EST1del179 GAGTGCATGCTCAGGGAGAATCATACACATAATCG 
Xba2 rev CATTCGTTCTTACAACGCATCATTGA 
Est3 Fusion rev TTAATTAACCCGGGGATCCGTCATAAATATTTATATACAA 
ATGGGAAAGT 
Fusion NAT for ACTTTCCCATTTGTATATAAATATTTATGACGGATCCCCGG 
GTTAATTAA 
NAT EST2 rev GCAATATTTTCCTTATCAGCATCATAAGCTGTCAGTATTTC 
ATGTATTATTAGTAGATATCATCGATGAATTCGAGCTC 
Est2 TEF for CTACTTTACTAGTTAGTTTACTTCCATGAATACAAAAGCAA 
AAATCATATACGGAGCTCATAGCTTCAAAATG 
Est2 TEF Rev CAATGTCAAGCTTGTCTTGAATGAACTCGAATAAGATTTTC 
ATGTTCTAGAAAACTTAGATTAGATTGC 
M13R CAGGAAACAGCTATGAC 
H primer For GAGTTCATTCAAGACAAGCTTG 
3 rev GAGGATGATCGTTGAGCCCATTTG 
EST1 TRP For (OP9806) GCAAACTTATCAGGGGAAAAAGTATATTCCATTAAATGA 
CACATGCCACCATAGATACGGATCCCCGGGTTAATTAA 
EST1 KO Rev2 CGTCGTCATAATATATTTCATATTATGATTTTTTCCCTCAC 
CATTACTTGTTCTCGATATCATCGATGAATTCGAGCTCG 
Top HA-Sfo-HA CATGTACCCGTATGATGTCCCAGACTATGCCCCTGGCG 
CCCCCTATCCTTACGACGTTCCGGACTACGCATGTAC 
Bot HA-Sfo-HA ATGCGTAGTCCGGAACGTCGTAAGGATAGGGGGCGCCA 
GGGGCATAGTCTGGGACATCATACGGGTACATGGTAC 
EST3R (OP6589) CTTTATATATGTAGATAAACGAAG 
XbaI FI CATCATTCTAGACGGATCCCCGGGTTAATTAAGG 
XbaI R2 ATGATGTCTAGACATCGATGAATTCGAGCTCG 
Bar1 For (BAR2529) GTTTATAGATAACGGCTCTTGC 
Bar1 Rev (BAR2530) CGTTTGGTTAGTTCAGCTAGG 
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Table 2.  Yeast strains 
 
Strain Genotype Source 
AVL78 MATa leu2 trp1 ura3-52 prb1 prc1 
pep4-3 
V. Lundblad 
YKF122 AVL78 est3::KANR J. Talley 
YKF122 est2::HYGR YKF122 est2::HYGR J. Talley/L. Maness 
1,2,3Δ AVL78 est3::KANR est2::HYGR 
est1::NATR 
This study 
YKF110 AVL78 EST3-HA3 K. Benton 
AVL78 Myc9-EST2 AVL78 Myc9-EST2 M. Platts 
AVL78 bar1::KANR AVL78 bar1::KANR G. Todd 
AVL78 Myc9-EST2 
bar1::KANR 
AVL78 Myc9-EST2 bar1::KANR This study 
AVL78 EST3-HA9 
bar1::KANR 
AVL78 EST3-HA9 bar1::KANR This study 
AVL78 Myc9-EST2 
EST3-HA9 bar1::KANR 
AVL78 Myc9-EST2 EST3-HA9 
bar1::KANR 
This study 
YKF122 fusion  AVL78 est3::KANR est2::EST2-G8-EST3 This study 
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Table 3.  Plasmids 
 
Plasmid Genotype Source 
pFA6a NAT-MX6 NATR AmpR T. Graham 
pKF408 integrating vector URA3 EST2 K. Friedman 
pKF408 trunc integrating vector URA3 EST2 minus 
C terminus from internal SpeI site 
This study 
pKF408 trunc TEF integrating vector URA3 EST2 minus 
C terminus and EST2 promoter 
replaced with TEF promoter 
This study 
pKF428 fusion 2µm TRP1 EST2-G8-EST3 J. Talley/L. Maness 
pKF431 CEN URA3 EST3 (ORF flanked by 
SacI and KpnI sites 
M. Platts 
pKF441 CEN URA3 EST3 (no N-terminal SacI 
site) 
J. Talley 
pKF442 CEN URA3 EST3-HA3 (no SacI site) M. Platts 
pKF444 2µm URA3 EST3-EST2 J. Talley/L. Maness 
pKF600 2µm LEU2 GALp-HA3-EST1 This study 
pKF610 CEN LEU2 EST1  (no BamHI site in 
MCS) 
This study 
pKF611 CEN LEU2 HA3-EST1  (no BamHI 
site in MCS) 
This study 
pRS306 integrating vector URA3 T. Graham 
pRS306 EST3-HA3 integrating vector URA3 EST3-HA3 This study 
pRS306 EST3-HA7 integrating vector URA3 EST3-HA7 This study 
pRS306 EST3-HA9 integrating vector URA3 EST3-HA9 This study 
pRS315 CEN LEU2 T. Graham 
pRS315 EST1 CEN LEU2 EST1 This study 
pRS315 HA3-EST1   CEN LEU2 HA3-EST1 This study 
pRS315 est1-Δ19 CEN LEU2 est1-Δ19  This study 
pRS315 HA3- est1-Δ19 CEN LEU2 HA3- est1-Δ19  This study 
pRS416 CEN URA3 T. Graham 
pRS416 EST1 CEN URA3 EST1 J. Ferguson 
pRS416 HA3-EST1 CEN URA3 HA3-EST1 J. Ferguson 
pRS416 EST3-HA9 CEN URA3 EST3-HA9 This study 
pRS416 EST3-HA9 NATR CEN URA3 EST3-HA9 NATR This study 
pRS423 GAL-HA3-EST1 2µm HIS3 GALp-HA3-EST1 A. Sathiyakumar 
pRS425 2µm LEU2 T. Graham 
pVL1633 2µm TRP1 est1-Δ19-Myc18 V. Lundblad 
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CHAPTER III 
 
RESULTS AND DISCUSSION 
 
Identifying a putative Est3p recruitment domain in Est1p 
 Previous analysis indicates that Est1p stimulates, but is not absolutely required, 
for the assembly of Est3p with yeast telomerase85.  The goal of this study is to identify 
residues of the Est1 protein that are required for stimulating the recruitment of Est3p to 
the complex.  I sought separation-of-function alleles of EST1 disrupted solely for this 
stimulatory function by screening for Est1p mutants that retain association with the 
catalytic core (Est2p and TLC1 RNA) but lack the ability to stimulate Est3p recruitment.  
I hypothesized that such alleles of EST1 could be isolated with the in vivo approaches 
described below and that characterization of these alleles might elucidate the regulation 
of Est3p assembly with telomerase.   
 Over-expression of Est1p increases the co-immunoprecipitation of Est3p with 
Est2p, an effect that is exaggerated in G1-arrested cells.  At this time in the cell cycle, 
endogenous Est1p is degraded in a proteasome-dependent manner, and Est3p association 
with the telomerase core is below the level of detection85.  From these observations, it 
was concluded that the cell cycle-regulated reduction in Est1 protein levels temporally 
restricts telomerase assembly, with Est1p as the limiting factor in complex formation.  
Over-expression of Est1p in G1 phase facilitates recruitment of Est3p to the telomerase 
holoenzyme, allowing me to detect differences in association of the telomerase 
components.  I took advantage of this phenomenon to screen for Est1p alleles unable to 
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stimulate Est3p recruitment.   Plasmid-born alleles of HA3-EST1 under control of a 
galactose-inducible promoter were transformed into strains containing integrated copies 
of Myc9-EST2 and EST3-HA3 (and expressing endogenous, untagged EST1).  HA3-Est1p 
over-expression was induced upon addition of galactose to G1-arrested cultures.  Myc9-
Est2p was immunoprecipitated from whole cell extract, and the co-immunoprecipitation 
(co-IP) of HA3-Est1p and Est3p-HA3 was monitored via Western blot.   
 While protein over-expression can lead to artifacts, it is often necessary due to the 
relatively low abundance of the four telomerase holoenzyme components78,86.  The over-
expression system used here has several advantages.  First, it allows for simultaneous 
assessment of the ability of an Est1p variant to retain association with Est2p and its 
ability to stimulate the association between Est2p and Est3p.  Second, untagged 
endogenous Est1p is present, so the effect of mutant alleles of EST1 can be monitored 
without the concern of cellular senescence.  Third, over-expression makes visualization 
and manipulation of the complex constituents easier.  For example, over-expression of 
different alleles of EST1 during G1 phase (when the endogenous protein is degraded) 
forces the telomerase complex to assemble with the mutant Est1 proteins, ensuring that 
the effect of the mutant protein can be specifically examined.   
 Although the residues required for the interaction of Est1p with Est2p have not 
been specifically mapped, a former lab member had previously observed that degradation 
products of Est1p retained the ability to co-IP with Myc9-Est2p (J. Osterhage, 
unpublished data).  These variants were detected by the HA antibody and therefore 
corresponded to C-terminal degradation products of the N-terminally tagged HA3-Est1p.   
These observations suggested that the C terminus of Est1p is not required for Est2p 
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association.  It was reasoned that analysis of progressively larger deletions from the Est1p 
C terminus might serve as a method to identify a region of Est1p required to stimulate 
recruitment of Est3p to the telomerase complex.   A series of truncation mutants was 
constructed with amino acids deleted from the C terminus in 50-amino acid blocks (i.e.: 
Δ50, Δ100, Δ150, …Δ500) and analyzed in the assembly assay described above for loss 
of co-IP of Est3p-HA3.  Another previous lab member preliminarily showed that deletion 
of the C-terminal 150 amino acids of Est1p resulted in loss of Est3p-HA3 co-
immunoprecipitation, whereas deletion of 100 amino acids from the Est1p C terminus 
retained the co-immunoprecipitation of Est3p-HA3 (A. Sathiyakumar, unpublished data). 
 I extended these preliminary studies by creating additional truncation variants and 
by altering the experimental conditions to improve protein detection.  Upon initial 
examination, I found that the Est1CΔ150 protein was not reproducibly co-
immunoprecipitated by Myc-Est2p.  Later sequencing revealed an unrelated mutation that 
likely disrupted protein folding such that it could no longer associate with the telomerase 
core.  Analysis with other deletion mutants showed that Est3p-HA3 co-IP was lost when 
the C-terminal 200 amino acids of Est1p were deleted but was retained when 136 amino 
acids were deleted from the C terminus of Est1p (Figure 5).  While these data suggest 
that a putative Est3p recruitment domain lies between residues 499 and 563 within the 
Est1 protein, no single technical repeat with all the pertinent samples provided 
quantifiable signals for the tagged Est proteins. 
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Figure 5.  Co-immunoprecipitation of Est3p-HA3 is lost when the C-terminal 200 
amino acids of Est1p are deleted.  Strains expressing Est3p-HA3 or Est3p-HA3 and 
Myc9-Est2p were arrested in G1 phase with alpha factor.  Over-expression of the 
indicated alleles of HA3-EST1 was induced by addition of galactose. Myc9-Est2p was 
immunoprecipitated from whole cell extract using Protein G sepharose beads bound to α-
c-Myc.  Proteins were separated by gel electrophoresis on a 10% SDS polyacrylamide 
gel.  Western membrane was probed with α-c-Myc and α-HA antibodies. 
 
 
Protocol development 
Two issues prevented the acquisition of reproducible and quantifiable data.  First, 
I observed background binding of Est3p to the beads, even in the absence of a Myc tag on 
Est2p.  Second, background signal from the light chain of IgG interfered with the 
detection of Est3p-HA3 because these two proteins migrate very similarly on the SDS-
PAGE gels used here. Despite using antibodies from different sources for the 
immunoprecipitation and detection, IgG cross-reacts with the α-Myc primary antibody.  
Combined, these two issues made it difficult to identify specific co-immunoprecipitation 
of Est3p.  Several approaches to circumvent these issues were pursued.   
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 To address the background binding by Est3p, the extract concentration was 
reduced prior to immunoprecipitation (IP).  I also determined a baseline of Est3p-HA3 
background binding to the beads.  In these “beads only” samples, Protein G sepharose 
beads (without antibody) were added to protein extract.  The volume of beads added to 
the extract was titrated to find a level that minimized the Est3p-HA3 background signal.  
Increasing the detergent and salt concentrations in the wash buffers and using different 
detergents were methods also explored to reduce non-specific interaction of Est3p-HA3 
during the IP procedure.   
To improve protein detection via Western blotting, primary antibody 
concentrations were altered in combination with changes to the concentration of milk and 
detergent in the blocking solution.  Detergent concentration in the wash buffers was also 
changed to decrease interference.  
 The main approaches used to address the light chain interference were 
crosslinking and improving separation between IgG and Est3p-HA3.  The Pierce 
Crosslinking Immunoprecipitation Kit was utilized to crosslink the Myc probe to  
Protein G sepharose beads for immunoprecipitation of Myc9-Est2p.  Preliminary results 
suggested that while the IgG light chain signal was reduced by crosslinking, so was the 
efficiency of the immunoprecipitation (data not shown).  However, there remain several 
options for potential optimization for using this kit.  These include, but are not limited to, 
using a different combination of wash buffers (either from the kit and/or from lab 
immunoprecipitation protocols) and exploring other methods of elution and sample 
preparation for Western analysis, taking into consideration guidelines from the 
crosslinking kit.   
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 Extensive work was done to resolve the issue of separation between the IgG light 
chain and Est3-HA3 protein.  Initially, the percentage of acrylamide in the gels and the 
duration of electrophoresis were altered, but with no success.  Samples were then run on 
Invitrogen pre-cast gradient gels, which did improve detection of Myc9-Est2p and HA3-
Est1p, but did not resolve the light chain interference.  The best separation between the 
IgG background and Est3p-HA3 was achieved when samples were separated on a 10% to 
12% step gradient polyacrylamide gel, though even here, separation was variable and did 
not lend itself to consistently interpretable (quantifiable) results.   
 The sum of these efforts at optimizing the in vivo assembly assay allowed me to 
develop a protocol for the best quality results using the strains and tools available at the 
time.  The specifications of this protocol are described in Materials and Methods, and the 
best results are shown in Figure 6.  
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Figure 6.  Est3p-HA3 and the light chain of IgG are best separated on a step 
gradient gel.  Strains expressing Est3p-HA3 or Est3p-HA3 and Myc9-Est2p were arrested 
in G1 phase with alpha factor as indicated.  Over-expression HA3-EST1 was induced by 
addition of galactose.  Whole cell extract was made by glass bead lysis.  Myc9-Est2p was 
immunoprecipitated using Protein G sepharose beads.  Proteins were separated by gel 
electrophoresis on a 10% to 12% step gradient SDS polyacrylamide gel.  Western 
membrane was probed with α-c-Myc and α-HA antibodies.  Lane 1 is input from 
asynchronously growing cells in rich media.  Lanes 2-7 are Myc IP samples; the sample 
in Lane 2 was immunoprecipitated from the extract shown in Lane 1.  The higher 
molecular weight band in Lane 1 is a background band detected by the α-HA antibody.  
Myc-Est2p is not detected under these conditions in whole cell extract (data not shown). 
 
 
Increasing the epitope size on Est3p 
Because all attempts to eliminate interfering signal from the IgG light chain were 
unsuccessful, I decided the best method to clearly detect differences in the co-
immunoprecipitation of Est3p was to increase the size of the epitope on the protein.  I 
hypothesized that increasing the tag on Est3p from three to nine hemagglutinin molecules 
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would both allow for a stronger signal from Est3p on the Western blot and result in an 
Est3 protein that runs at a higher molecular weight than the IgG light chain for substantial 
separation of these proteins during gel electrophoresis.  EST3-HA9 was integrated at the 
endogenous EST3 locus in strains with and without endogenously-tagged Myc9-EST2.   
 EST3-HA9 complements the growth and telomere length defects of a strain lacking 
endogenous EST3 when expressed from a low copy vector (Figure 7).  Strains with 
integrated EST3-HA9 have shorter telomeres than a wild-type strain, similar to the 
shortening observed in a Myc9-EST2 strain.  Telomere shortening was exacerbated when 
both EST3-HA9 and Myc9-EST2 were expressed in yeast (Figure 8).  Est3p-HA9 was 
confirmed to migrate at a clearly distinguishable molecular weight from the light chain of 
IgG and at a lower molecular weight than the Est1CΔ250 protein, the smallest of the 
Est1p deletion mutants analyzed with the assembly assay (Figure 9).  Myc9-Est2p co-
immunoprecipitated Est3p-HA9 at levels clearly above background in asynchronously 
growing cells (Figure 10).   
 These data indicate that the Est3-HA9 protein is a promising tool for assessing the 
ability of mutant Est1 proteins to stimulate the co-immunoprecipitation of Est3p.  The 
Est3-HA9 protein product gives a stronger signal by Western blotting than the original 
allele (HA3) and migrates considerably more slowly in a gel than the light chain of IgG 
(Figure 9), negating the concern for interference from IgG as separation of these two 
proteins is easily accomplished.  This latter observation may also prove useful in the in 
vitro binding assay optimization described later.  Notably, a strain expressing the new 
EST3-HA9 allele has been utilized in the lab to probe the interaction between Est3p and 
Est2p.  In this instance, ProA-tagged alleles of EST2 are expressed in the strain with 
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integrated EST3-HA9; ProA-Est2p is immunoprecipitated from whole cell extract; and the 
co-immunoprecipitation of Est3p-HA9 is determined by Western analysis.  
Encouragingly, the signal of Est3p-HA9 is quantifiable in these experiments and has been 
used to determine quantitative differences in the ability of various Est2p mutants to co-
immunoprecipitate Est3p-HA9 (L. Bechard, unpublished data). 
 Unfortunately, co-expression of Est3p-HA9 and Myc9-Est2p enhances the 
telomere shortening effect that each epitope confers individually (Figure 8).  Such short 
telomeres at the start of further manipulations to the strain could lead to senescence 
before whole cell extract can be harvested.  Specifically, cells expressing both tagged 
proteins seem to grow poorly when the GALp-HA3-EST1 over-expression vector is 
introduced (data not shown), perhaps due to the requirement for growth in selective 
media.  Further adjustments to improve the growth of this strain are needed to fulfill the 
potential of using Est3p-HA9 for these studies.  One possibility is to incorporate a linker 
between Est3p and the series of HA tags, a strategy that has been shown to improve 
telomere length maintenance upon tagging of other yeast telomerase components78,87. 
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Figure 7.  Est3p-HA9 complements the telomere length defects of a strain lacking 
endogenous EST3.  Genomic DNA was isolated by glass bead lysis and phenol-
chloroform extraction, digested with XhoI, and separated by gel electrophoresis.  
Telomeres were detected by a randomly-labeled probe.  Lanes 1 and 2: wild-type AVL78 
cells grown in rich media.  For lanes 3-11, cells were passaged three times on media 
lacking uracil to maintain the specified plasmid; all vector backbones are pRS416 (CEN 
URA3).  Lanes 3-5: three independent transformants containing empty vector (EV); lanes 
6-8: three independent transformants containing an EST3 complementing plasmid; lanes 
9-11: three independent transformants containing a plasmid expressing EST3-HA9. 
 34 
 
 
Figure 8.  Epitopes on telomerase proteins cause telomere shortening.  Each lane 
represents an independent colony that was passaged three times on rich media.  Genomic 
DNA was isolated by glass bead lysis and phenol-chloroform extraction, digested with 
XhoI, and separated by gel electrophoresis.  Telomeres were detected by a randomly-
labeled probe.  Tagged alleles were integrated at the endogenous locus; strains without 
tags retained endogenous genes.  Lane 1: wild-type AVL78; Lanes 2 and 3:  AVL78 
bar1::KANR; Lanes 4 and 5: AVL78 Myc9-EST2 bar1::KANR; Lanes 6-9: AVL78 EST3-
HA9 bar1::KANR; Lanes 10-17: AVL78 Myc9-EST2 EST3-HA9 bar1::KANR. 
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Figure 9.  Est3p-HA9 migrates slower than the IgG light chain but faster than 
Est1pCΔ250.  Proteins were separated on a 10% SDS polyacrylamide gel and detected 
with α-HA.  A. Lanes: 1) Extract from a strain with endogenously-tagged EST3-HA3 
arrested in G1 phase, 2) Extract from a strain with endogenously-tagged EST3-HA3 and 
plasmid overexpressing HA3-EST1Δ250, arrested in G1 phase, 3) Myc IP from a strain 
with endogenously-tagged Myc9-EST2 and EST3-HA3 grown asynchronously, 4) Protein 
isolated by trichloroacetic acid (TCA) precipitation from an est3Δ strain expressing 
plasmid-born, untagged EST3, 5) TCA prep from the same est3Δ strain expressing 
plasmid-born EST3-HA9.  B. Lanes 1-3: Extract from strains over-expressing plasmid-
born HA3-EST1, HA3-EST1CΔ200, or HA3-EST1CΔ250, respectively.  Lane 4: TCA prep 
from est3Δ strain expressing plasmid-born EST3-HA9 (same as in Panel A, Lane 5).  
Note: The gels here were run for the same duration, but in future analyses, 
electrophoresis time will be increased to run the IgG light chain off the gel for greater 
separation between Est3p-HA9 and Est1pCΔ250.  
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Figure 10.  Myc9-Est2p specifically co-immunoprecipitates Est3p-HA9.  Strains 
expressing Est3p-HA9 or Est3p-HA9 and Myc9-Est2p were grown asynchronously in rich 
media.  Whole cell extract was made by glass bead lysis.  Myc9-Est2p was 
immunoprecipitated using Protein G sepharose beads.  Proteins were separated by gel 
electrophoresis on a 10% SDS polyacrylamide gel.  Western membrane was probed with 
α-c-Myc and α-HA antibodies.  Lanes 1 and 2 are extract samples obtained before (lane 
1) and after (lane 2) incubation with the beads from the sample in Lane 5.  Lanes 3 and 4 
were taken before (lane 3) and after (lane 4) incubation with the beads from the sample in 
Lane 6.  The higher molecular weight band in Lanes 1-4 is a background band detected 
by the α-HA antibody. 
 
 
Screening for est1 alleles disrupted specifically for stimulating Est3p recruitment† 
 As development of the assembly assay continues, screening for est1 alleles unable 
to stimulate Est3p recruitment is a highly complementary approach.  I have designed two 
genetic screens to identify alleles of EST1 disrupted solely for the ability to stimulate 
recruitment of Est3p to the telomerase complex.  The first of these screens utilizes an 
Est2-Est3 fusion protein expressed from the EST2 locus in a strain lacking endogenous 
EST3 and the other uses a galactose-inducible allele of EST3 integrated at the EST1 locus.  
                                                
† Work from this section was contributed by graduate rotation students as indicated in the text: Caroline 
Wiser, Stacey Lawrence, Derrick Cumberbatch. 
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In both cases, est1 alleles generated by random or directed mutagenesis are screened for 
suppression of growth defects by expression of the Est2p-Est3p fusion or by over-
expression of Est3p.  Alleles of EST1 lacking the ability to stimulate Est3p recruitment 
are expected to display telomere loss and senescence in the presence of endogenously 
expressed Est2p and Est3p, but growth and telomere length are expected to be rescued by 
co-expression with the Est2-Est3p fusion protein and/or over-expressed Est3p.   
 We reason that expression of Est2p and Est3p as a single protein will eliminate 
the requirement for Est1p in recruiting Est3p to telomerase.  This fusion protein is not 
expected to bypass any other function of the Est1 protein, and we predict that Est1p has 
other essential functions.  Therefore, alleles isolated here are expected to be separation-
of-function alleles specifically disrupted for stimulating Est3p recruitment.  Importantly, 
the Est2p-Est3p fusion containing an eight-glycine (G8) linker between the individual 
polypeptides is competent for telomere maintenance; it complements the growth and 
telomere length defects of cells lacking endogenous EST2 and EST3 when expressed 
from a high copy number plasmid.  Note that the telomere length is almost fully rescued, 
but not completely to wild-type length (J. Talley and L. Maness, unpublished data).   
For use in my screen, the Est2p-Est3p fusion needed to be the only version of the 
Est2 and Est3 proteins expressed in the cell.  Endogenous Est2p and Est3p may compete 
with the fusion protein for interaction with Est1p mutants, decreasing the chance of 
suppression.  To create the appropriate strain, EST2-G8-EST3 was integrated into the 
endogenous EST2 locus of a strain lacking EST3 (C. Wiser).  The resulting strain 
expresses only fused Est2p and Est3p driven by the EST2 promoter.  However, Southern 
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blot analysis revealed that this strain maintains very short telomeres (C. Wiser, S. 
Lawrence, unpublished data).   
With such short telomeres, we hypothesized that rescue of any defect due to Est1p 
mutants by the Est2p-Est3p fusion would have to be complete, or nearly so; otherwise the 
cells would senesce and form survivors (which maintain telomeres via a recombination-
based mechanism)88.  While this strain background could provide a very stringent test for 
rescue by the fusion protein, I was also interested in finding mutants of Est1p that may 
not be fully rescued by the Est2-Est3 fusion protein.  To allow for the possibility of 
isolating such alleles of EST1, we sought to increase the steady-state telomere length in 
the Est2-Est3 fusion strain and simultaneously pursued the approaches below.   
First, we reconstructed the fusion-expressing strain by integrating EST2-G8-EST3 
into another est3Δ strain containing a different EST3 complementing plasmid that permits 
maintenance of nearly wild-type length telomeres.  The final fusion-containing strain 
maintains telomeres near wild-type length (S. Lawrence, unpublished data). 
Second, we speculated that driving higher expression of the Est2-Est3 fusion 
protein may permit the cell to maintain longer telomeres.  This idea was based on the 
observation that the Est2p-Est3p fusion complemented the telomere length of an 
est2Δest3Δ strain when expressed from a high copy number vector better than when 
expressed from a centromere plasmid (J. Talley and L. Maness, unpublished data).  To 
increase Est2-Est3 protein levels, we designed a method to replace the EST2 promoter 
with the constitutively active TEF1 promoter directly upstream of the EST2-G8-EST3 
fusion by two-step integration.  To date, the first step of integration of the TEF promoter 
at the EST2-G8-EST3 locus has been confirmed by Southern blot (D. Cumberbatch, 
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unpublished data); however, strains in which recombination has replaced the EST2 
promoter with the TEF promoter have not yet been isolated. 
The last step in creating the strains for this screen is to replace endogenous EST1 
with the hygromycin-resistance gene (HYGR).  The resulting strains will express only 
fused Est2p and Est3p and express EST1 from a URA3-marked complementing plasmid 
that can be selected against when mutagenized est1 alleles are introduced into the cell on 
a LEU2-marked plasmid (Figure 11).  I first want to test the deletion alleles created for 
the in vivo assembly assay in this fusion-expressing strain.  Because the C-terminal 
truncation mutants were originally constructed in an over-expression vector and driven 
by the GAL1 promoter, I have constructed a centromere (low copy) vector with 
compatible restriction sites that will allow easy transfer of these alleles to a vector 
suitable for my genetic screens.     
 
 
 
Figure 11.  Schematic of plasmid shuffle to screen plasmid-born alleles of EST1 for 
rescue by the Est2-Est3 fusion protein.  A strain lacking endogenous EST1 and EST3 
with the EST2-G8-EST3 fusion integrated into the genome at the EST2 locus contains a 
URA3-marked EST1 complementing plasmid that is maintained by growth on media 
lacking uracil.  Alleles of EST1 contained on a LEU2-marked centromere plasmid are 
transformed into this strain (1), and both plasmids are maintained by plating on media 
lacking uracil and leucine.  Loss of the complementing plasmid is selected by plating on 
5-fluoroorotic acid (2).  Surviving cells are passaged on media lacking leucine for 
observation of normal growth or senescence. 
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I have created a strain lacking endogenous EST1, EST2, and EST3, but while 
working through that process, I tested the feasibility of using the Est2-Est3 fusion protein 
as a tool for screening est1 mutants with growth and telomere length complementation 
analysis.  The caveat of this particular experiment is that the fusion protein is present in 
addition to endogenous EST2 and EST3.  Specifically, a TRP1-marked empty vector or 
high copy number vector with EST2-G8-EST3 was co-transformed into an est1Δ strain 
with a LEU2-marked EST1 complementing plasmid or low copy number plasmid 
containing the previously published est1-Δ19 allele52.  Cells were then passaged on media 
lacking tryptophan and leucine for observation of growth phenotypes before determining 
telomere length by Southern blot.  The Est2p-Est3p fusion was unable to rescue the 
senescence and telomere loss of a strain completely lacking EST1.  This result was 
expected, since this fusion protein should not be able to bypass Est1p’s other functions, 
such as recruitment of telomerase to the telomere.  In contrast, when the Est2p-Est3p 
fusion was co-expressed with wild-type Est1p, cells continued to grow normally and 
telomeres were maintained at nearly wild-type length.  Similar to the empty-vector 
control, cells co-expressing EST2-G8-EST3 and est1-Δ19 senesced and formed survivors 
(Figure 12).   
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Figure 12.  EST2-G8-EST3 does not suppress the telomere shortening of the est1-Δ19 
allele.  Plasmid-born EST2-G8-EST3 and either EST1 or est1Δ19 were co-transformed 
into a strain lacking endogenous EST1.  Each lane represents a single transformant that 
was passaged five times on media lacking tryptophan and leucine.  Genomic DNA was 
isolated by phenol-chloroform extraction, digested with XhoI, and separated by gel 
electrophoresis.  Telomeres were detected by a randomly-labeled probe.  
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As described above, the est1-Δ19 allele is hypothesized to be defective for an 
activation function of Est1p.  est1-Δ19 contains a deletion of amino acids 499 to 518, a 
region within Est1p’s proposed DNA- and RNA-binding domains and the EF hand-like 
motif needed for G quadruplex formation (Figure 4).  Because this deletion is predicted 
to compromise several functions of Est1p, it is not surprising that EST2-G8-EST3 fails to 
rescue the growth and telomere length defects of est1-Δ19.  Therefore, the results shown 
in Figure 12 support the notion that the Est2-Est3 fusion protein does not bypass 
functions of Est1p other than stimulating Est3p recruitment.  However, until an allele of 
EST1 that is rescued by the fusion protein is isolated, we cannot be sure that the Est2p-
Est3p fusion can suppress any function of Est1p. 
 The second screening method tests whether est1 phenotypes can be rescued by 
EST3 over-expression.  Here, alleles of EST1 disrupted for stimulating Est3p recruitment 
are hypothesized to grow normally and maintain telomeres when Est3p is over-expressed, 
but senesce when Est3p is expressed at its endogenous levels.  Strain construction for this 
screen is straightforward.  Briefly, the GAL1 promoter, EST3 open reading frame (ORF) 
and terminator, and NATR gene will be amplified as a single PCR product with flanking 
homology to the EST1 locus.  Integration of this construct into the yeast genome will 
simultaneously remove endogenous Est1p and introduce an inducible allele of EST3 (in 
addition to the endogenous EST3 gene).  Combining these steps reduces the required 
number of nutritional or drug-resistance markers and circumvents the need for additional 
plasmids (in contrast to the experiment shown in Figure 12).  The resulting strain will be 
complemented with a CEN URA3 EST1 plasmid.  For this screen, the same est1-bearing 
plasmids mentioned above will be transformed on media containing galactose.  Loss of 
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the EST1 complementing plasmid will be selected on 5-FOA.  Single colonies will be 
restreaked onto selective media containing galactose.  Surviving colonies will then be 
passaged on selective media containing glucose, inhibiting over-expression of Est3p.  
Those strains that survive upon galactose but undergo senescence on glucose may contain 
alleles of EST1 that are specifically defective in Est3p recruitment to the telomerase 
complex. 
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CHAPTER IV 
 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
 In this study, I have pursued a variety of approaches to address the role of the 
Est1 protein in the assembly of Est3p with the telomerase holoenzyme.  The Friedman 
laboratory has published that Est1p is both necessary and sufficient for Est3p assembly 
with the complex85, and the Zakian group has obtained chromatin immunoprecipitation 
data consistent with this model72,81.  However, the Lundblad lab argues that Est3p can 
interact with telomerase in the absence of Est1p34,43.  Based on the observation that Est2p 
and Est3p directly interact77, I hypothesize that Est3p has a low basal ability to interact 
with the telomerase holoenzyme and that Est1p stimulates this recruitment during S 
phase.  I have applied an in vivo co-immunoprecipitation assay and two genetic screens to 
identify alleles of EST1 disrupted for this stimulatory function.   The mechanism through 
which Est1p recruits Est3p to the telomerase complex may be clarified through the 
identification of EST1 alleles that retain other essential functions but specifically lose the 
ability to recruit Est3p.  
 
Putative Est3p recruitment domain 
 Over-expression of Est1p increases the co-immunoprecipitation of Est3p with 
Est2p compared to wild-type cells85.  Using an in vivo assembly assay, I tentatively 
determined that the region of Est1p responsible for stimulating the recruitment of Est3p 
lies between amino acids 499 and 563 (Figure 5).  Other deletion mutants were designed 
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based on sequence conservation within this domain and will be analyzed with the 
intention of further dividing this putative Est3p recruitment domain into groups of 11 to 
21 amino acids.  Unfortunately, as described earlier, satisfactory resolution of this 
question awaits the development of an improved method to detect co-
immunoprecipitation of Est3p.  
Once the deletion mutants have been used to define a small region of Est1p 
required for Est3p recruitment, single amino acid (or point) mutations can be made within 
that region to identify residues responsible for this function of Est1p.  Importantly, point 
mutations should not be limited to alanine, and sequence conservation and proposed 
structural elements of Est1p should be taken into consideration when determining which 
mutant alleles are to be introduced into the assembly assay.  In particular, the choice of 
mutations within the EF hand-like motif important in Est1p’s G quadruplex-promoting 
activity39 should be informed by the potential for interrupting the motif, which could lead 
to general protein instability instead of disruption of a specific function.  For example, 
within the ion-coordinating residues of the EF hand-like motif, mutation of larger 
charged residues to alanine will likely produce different phenotypic manifestations than if 
those same residues were mutated to the oppositely-charged or a neutral amino acid with 
a side chain of similar size and shape.  Therefore, various types of mutations will be 
examined because differences between mutations of the same amino acid may hint at the 
mechanism by which Est1p stimulates Est3p’s assembly with telomerase.  For instance, if 
a charge reversal mutation loses the ability to stimulate the co-immunoprecipitation of 
Est3p, then the mutated residue may more likely be involved in a direct protein-protein 
interaction with Est3p.  If such an allele of EST1 were identified as a separation-of-
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function allele (discussed below), then a series of experiments to identify the reciprocal 
residue in Est3p would be useful for clarifying the current model of yeast telomerase 
assembly. 
 
Screening for Est1p mutants disrupted for stimulating recruitment of Est3p 
 I have designed two genetic screens for isolating alleles of EST1 specifically 
disrupted for stimulating the recruitment of Est3p to the telomerase complex.  The first 
uses an Est2-Est3 fusion protein and the second utilizes over-expressed Est3p to bypass 
the Est3p recruitment function of the Est1 protein.  Strain and plasmid construction for 
both screens is underway. 
 A final topic I addressed while designing these screens concerns how 
mutagenized alleles of EST1 will be introduced into the yeast strains.  Randomly 
mutagenized alleles will be generated via PCR mutagenesis and/or passage through a 
mutagenic strain of E. coli.  If gap repair is used to introduce est1 alleles into the strains, 
pKF610 est1CΔ250 may serve as appropriate vector.  Gap repair relies on the cell’s 
ability to perform homologous recombination (HR), and therefore requires the HR 
protein Rad52.  Unfortunately, the presence of RAD52 can confound the interpretation of 
genetic screens involving telomerase function.  If cells lose the ability to maintain 
telomeres with telomerase, a recombination-based method dependent on Rad52p is 
utilized to amplify sub-telomeric regions to retain the telomere capping function88.  In 
this instance, the role of telomerase in telomere maintenance can no longer be examined.  
For example, if the Est2p-Est3p fusion fails to rescue defects of a mutant Est1 protein, 
RAD52 cells will undergo senescence and form survivors, which can be difficult to 
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discern as it occurs on solid agar media and can only be confirmed with Southern blot 
analysis of telomere length.  In contrast, cells lacking RAD52 will eventually fail to 
divide, a phenotype much more evident on solid media.  The fusion-expressing and Est3p 
over-expression strains were intentionally constructed to allow for the deletion of 
endogenous RAD52.  Another option is to introduce mutagenized EST1 using a plasmid 
library, which does not require RAD52.  One potential drawback to creating a plasmid 
library is that sufficient complexity requires very high ligation efficiency of mutagenized 
gene inserts into the vector backbone, which can be difficult to achieve.  Due to the 
nature of my design, though, either of these approaches is possible for executing these 
screens for mutant alleles of EST1 incapable of stimulating the recruitment of Est3p. 
 
Alternative approach 
 To perform the screen with the Est2-Est3 fusion protein, mutagenized alleles of 
EST1 will be expressed in two strains.  The control strain will only lack endogenous 
EST1 and contain wild-type EST2 and EST3.  The experimental strain will lack 
endogenous EST1 and EST3, while the endogenous EST2 gene is replaced with the EST2-
G8-EST3 fusion construct.  Plasmids containing mutant est1 alleles (obtained through 
either random or directed mutagenesis) can be transformed into these strains and the 
complementing plasmid selected against by plating cells on 5-fluoroorotic acid (5-FOA). 
This approach will be most easily applied with specific mutants that are isolated from the 
in vivo over-expression/co-immunoprecipitation assay described above because 
interpretation of the results requires that growth of a specific mutant est1 allele be 
monitored separately in the control and fusion strains.   
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A more efficient way to examine rescue by the fusion protein is to have the ability 
to turn expression of Est2p-Est3p on and off within the same cell, but without 
competition from free Est2p and Est3p.  This experimental design would allow for 
selection of est1 alleles that are suppressed in the presence of the fusion protein, but not 
in its absence.  One approach to create an “inducible fusion” strain would be to express 
versions of Est2p and Est3p fused to protein domains that dimerize when in the presence 
of the drug rapamycin89.  Transformants with plasmids bearing alleles of EST1 would be 
plated on media containing and lacking rapamycin, and their growth tracked on each 
medium over time, followed by telomere length analysis.  The constructs required for this 
screen are available in the Friedman laboratory; however, time did not permit me to 
explore the various options that may have allowed me to use the “inducible fusion” for 
my studies.  One issue to be considered if this approach is undertaken: the placement of 
epitopes, including these dimerization domains, on telomerase components can be 
extremely important in terms of allowing the complex to maintain telomeres (L. Bechard, 
unpublished data).  Therefore, the protein domains may need to be tested at each terminus 
of both Est2p and Est3p to determine the optimal configuration for this assay.  Another 
caveat to this system is that it relies upon use of a rapamycin-resistant yeast strain.   
 
Interpretation: Mechanism of assembly 
 The Est2p-Est3p fusion is predicted to bypass the need for Est1p to stimulate 
Est3p association by constitutively tethering Est3p to the telomerase core (but is not 
expected to rescue other functions of Est1p).  Over-expression of Est3p might permit 
more efficient assembly with the complex due to higher protein abundance, thus 
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bypassing the need for Est1p in Est3p recruitment.   Each of these screening methods has 
its advantages.  Excess levels of Est3p due to over-expression could lead to isolation of 
false positives because such high protein levels may also allow for non-specific 
interactions to occur within the complex or alterations in other cellular processes that 
somehow rescue defects of the est1 allele in the cell.  Use of the Est2-Est3 fusion protein 
does not introduce this variable into the system.  However, the fusion protein does 
present one considerable limitation: the protein conformation and potential interaction 
surfaces of Est2p and Est3p are restricted when expressed as a fusion.  Presumably, Est2p 
and Est3p are in approximately the correct configuration for telomere maintenance 
because the fusion protein complements the absence of endogenous EST2 and EST3.  
Though the eight-glycine linker was determined to be ideal for telomere maintenance 
(Friedman lab, unpublished data), there is still limited flexibility of proteins to fold and 
move and be accessible to binding partners when they are joined together.  Another 
possibility is that simply getting Est3p into the complex is insufficient for function and 
that Est1p is required to induce a specific interaction not bypassed by the fusion alone.  
This particular caveat is not an issue when over-expressing Est3p, because in these cells, 
the free telomerase proteins are translated individually as usual and have the opportunity 
to be in any conformational state they might normally take.  In view of these differences, 
it is important to utilize both of these screening methods to isolate and test alleles of 
EST1 that are disrupted for stimulating recruitment of Est3p to the telomerase complex.  
In particular, the strains created for isolating new est1 alleles for analysis in the assembly 
assay can also be used to analyze est1 mutants that display reduced or absent Est3p  
co-immunoprecipitation as a form of confirmation of the validity of the assembly assay.   
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Additionally, as suggested, using both screening methods may allow for 
interpretation of potential mechanisms through which Est1p stimulates Est3p recruitment, 
particularly if an est1 mutant is rescued by either the fusion protein or over-expression of 
Est3p but not both.  Specifically, I hypothesize that Est1p mutants disrupted for a direct 
protein-protein interaction with Est3p would be rescued by co-expression with the Est2p-
Est3p fusion but not necessarily by over-expressing Est3p.  If the defect in recruiting 
Est3p were not profound, over-expressing Est3p might also rescue the growth and 
telomere phenotypes of such mutants.  And I would expect mutants of Est1p lacking the 
ability to induce a conformational change in the complex for Est3p association to be 
rescued by Est3p over-expression but not by the presence of the Est2-Est3 fusion protein, 
which is likely unable to take all conformations the free telomerase proteins are capable 
of forming.  Isolating est1 alleles rescued by the fusion protein (and possibly over-
expression of Est3p) would support a model in which Est1p recruits Est3p to telomerase 
via a direct protein-protein interaction, as the Zakian lab has suggested78.  Another, not 
necessarily mutually exclusive, possibility is that Est1p confers a conformational change 
within the holoenzyme that increases the affinity of Est3p and Est2p.  This mechanism 
would be indicated by rescue in the presence of over-expressed Est3p but not necessarily 
by the Est2-Est3 fusion protein, again, due to the restriction of the fusion protein’s 
conformational state and ability to access binding partners.  This model is supported by 
data showing a direct interaction between the Est2 and Est3 proteins77.  Alternatively, 
since the function of Est3p is presently unknown, if its precise localization within the 
complex is critical for its in vivo function, the Est2-Est3 fusion protein may not be able to 
appropriately bypass the Est3p recruitment function of Est1p.  So even if no alleles of 
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EST1 are rescued by co-expression with the fusion protein, conclusions may still be 
drawn about the regulation of telomerase holoenzyme assembly and the specific role(s) 
for each component within the complex, though conclusions based on negative results 
should always be considered critically.  Therefore, nearly any finding from these screens 
would be important for the field in resolving the debate concerning precise assembly of 
telomerase, particularly as to the mechanism by which Est3p is assembled into the 
telomerase complex. 
 
In vitro binding assay 
 The Friedman laboratory has demonstrated that purified, recombinant Est2p and 
Est3p interact directly77.  However, the role of Est1p in modulating this interaction has 
not been explored.  One approach to this question is to assay the ability of recombinant 
Est3p to interact with telomerase in extract derived from strains expressing different 
alleles of EST1.  If the recombinant protein recapitulates the endogenous situation, we 
would predict that the interaction of Est3p with telomerase would be increased when 
Est1p is over-expressed in whole cell extract and decreased in the absence of Est1p or in 
the presence of Est1p variants that lack the ability to stimulate Est3p recruitment in vivo.  
The Zakian lab has recently shown that recombinant Est1 and Est3 proteins interact in 
vitro78, presenting a potential opportunity for collaboration to investigate the Est1p 
mutants I isolate in vivo in their in vitro assay.   
The in vitro binding assay uses purified, recombinant His6-Est3p mixed with 
whole cell extract lacking endogenous Est3p from which Myc-tagged Est2p is 
immunoprecipitated and probed for pull down of Est3p via Western analysis.  Different 
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aspects of this assay were briefly targeted for optimization, with the most focus being on 
incubation time of Est3p with the extract and detection of all pertinent proteins.  
Unfortunately, as with the in vivo assembly assay, clear interpretation of differences in 
Est3p pull down was confounded by high interference from the light chain of IgG.  While 
the step gradient gels mentioned earlier did allow for some separation between IgG and 
His6-Est3p (data not shown), changing the tag on Est3p would be the best method to 
resolve this issue.  There are several options for tagging Est3p with different epitopes, 
including MBP and GST tags previously used in the lab, in addition to the Est3-HA9 
protein discussed earlier, or epitopes that can be cleaved from Est3p following 
purification (J. Talley, personal communication).  Changing the epitope tag would likely 
require re-optimization of conditions to purify useful concentrations of quality protein.   
To further examine the role of Est1p in Est3p’s assembly with telomerase, 
different alleles of EST1 need to be analyzed with this assay.  One possibility for 
performing these experiments is to purify recombinant, epitope-tagged variants of Est1p 
and mix them in combination with purified Est3p and extract from strains lacking 
endogenous EST1 and EST3.  However, it is technically difficult to purify even wild-type 
Est1p from E. coli (J. Talley, personal communication), so another source of recombinant 
protein should be considered, such as wheat germ extract or rabbit reticulocyte lysate (J. 
Ferguson and K. Friedman, in preparation).   
An alternative approach is to express the mutant alleles of EST1 in vivo and to 
assay the effect of these mutations on the interaction of recombinant Est3p with the 
telomerase complex in extract.  Toward this end, I have constructed the plasmid pKF611 
to allow the expression of HA-tagged alleles of EST1 from a centromere plasmid with the 
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endogenous EST1 promoter and terminator.  This plasmid could replace the 
complementing plasmid in cells lacking endogenous EST1, but whole cell extract would 
need to be harvested before senescence.  Another option is to over-express tagged alleles 
of EST1 in G1-arrested cells (as in the in vivo assembly assay) or cells lacking 
endogenous EST1 (again harvesting extract before senescence).  Myc9-Est2p would be 
immunoprecipitated as before, and the pull down of His6-Est3p from each strain extract 
compared.  This method assumes that the variants of Est1p retain association with 
telomerase, a requirement for separation-of-function alleles as mentioned above.  While 
there are several technical difficulties to consider when pursuing the in vitro binding 
assay, it is a valuable tool for addressing my hypothesis.   
  
In vitro telomerase activity assay 
Independently, addition of recombinant Est1p or Est3p has been shown to 
enhance nucleotide addition by telomerase in vitro44,77.  This stimulation assay entails 
incubating telomerase partially purified from yeast extract with a biotinylated telomeric 
primer conjugated to magnetic streptavidin beads and determining the enzyme’s ability to 
add radio-labeled nucleotides to the primer by separating products on a 
urea/polyacrylamide gel.  A preliminary experiment from the Freeman lab suggested that 
Est1p is not required for the stimulation of telomerase activity by Est3p (B. Freeman, 
unpublished data).  However, simultaneous addition of both proteins has not been 
studied, and the potential interaction between the Est1 and Est3 proteins may also affect 
the enzymatic activity of telomerase.   
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One caveat of this assay is that it is not clear which telomerase components are 
present when the complex is purified from yeast.  While Est2p and TLC1 RNA must be 
present for catalytic activity to be retained, other components may not be purified at 
stoichiometric levels.  To ensure that wild-type Est1p is not present in the telomerase 
extract, strains lacking endogenous EST1 have been used as the source of telomerase for 
this assay44.  In the case of adding both recombinant Est1 and Est3 proteins, the 
suggested strain background to avoid any interference from wild-type proteins would be 
one lacking endogenous EST1 and EST3.  However, it may be difficult to obtain 
sufficient amounts of telomerase extract from yeast undergoing senescence due the lack 
of two telomerase components.  If it becomes necessary, options for obtaining 
individually purified telomerase components should be explored, as mentioned for the in 
vitro binding assay (above), including in vitro transcription and translation methods. 
If addition of Est1p and Est3p additively or synergistically increases in vitro 
telomerase activity, then this assay could be used to examine how interactions between 
the telomerase complex components contribute to the enzyme’s activity.  For example, if 
a direct interaction between the Est1 and Est3 proteins affects enzyme activity, mutants 
of Est1p disrupted for stimulating Est3p recruitment may be predicted to lack the ability 
to stimulate in vitro telomerase activity.  But, as with any in vitro experiment, the caveat 
must be noted that negative results could be attributed to the nature of the in vitro system, 
without post-translational modifications or potential telomerase-interacting factors, and 
may not reflect the role of telomerase components in the cell. 
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Separation of function within the Est1 protein 
 To demonstrate that alleles of EST1 identified by the experiments presented here 
are true separation-of-function alleles, representing residues only involved in stimulating 
the recruitment of Est3p, other studies must also be completed.  Variants of Est1p 
expressed from a centromere plasmid and driven by the endogenous EST1 promoter 
(pKF610; Table 3) will be examined for complementation of growth and telomere length 
defects of an est1∆ strain.  I predict that mutants defective for Est3p recruitment will fail 
to maintain telomere length.  In addition to stimulation of Est3p recruitment, Est1p’s 
ability to associate with telomerase is demonstrated by co-IP with Myc9-Est2p in the in 
vivo assembly assay.  The ability of the Est1 protein to specifically bind TLC1 will be 
assayed by examining the ability of HA3-Est1p to co-IP the TLC1 RNA as detected by 
Northern blotting.  The stimulation assay will determine whether the Est1p mutants retain 
the ability to enhance in vitro telomerase activity.  DNA binding can be assessed by 
electromobility shift assays with radio-labeled substrates.  Using the same in vitro assay 
as the Zhou group33, my Est1p mutants can also be tested for the ability to promote G 
quadruplex structures.  If any mutants isolated for the inability to stimulate Est3p 
recruitment retain the ability to perform all of these functions of Est1p, they would be 
considered true separation-of-function alleles of EST1.    
The stimulation assay could also be used to probe the relationship of Est1p’s 
various functions.  For instance, the Est1 protein has been shown to bind DNA 
substrates38; if this function of Est1p is important for telomerase activity, Est1 mutant 
proteins disrupted for binding DNA are predicted to not stimulate in vitro telomerase 
activity.  Notably, the G quadruplex (or G quartet)-promoting function of Est1p could be 
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tested by introducing Est1p mutants into the assay or by using different telomeric primers 
as substrates.  In particular, two types of primers should be compared in the stimulation 
assay: one that is incapable of forming higher order G quartets and one that can form G 
quadruplexes.  If the formation or stabilization of G quartets by Est1p is necessary for the 
protein’s contribution to telomerase activity, then the primer incapable of forming these 
DNA structures may not be elongated.  The hypothesis for any function of Est1p is: if the 
specified function is necessary for Est1p to affect telomerase activity, then mutants for 
that function will not show stimulation of primer extension above background. 
 One question remains: what if no separation-of-function allele of EST1 disrupted 
for stimulating recruitment of Est3p is identified?  This outcome is possible, if not likely, 
due to the fact that many of Est1p’s functions lie in essentially the same region of the 
protein.  If any Est3p recruitment mutants were also disrupted for even one other function 
of Est1p, it could be considered evidence of the significance of the region spanning 
approximately residues 450 to 550 in contributing to Est1p’s role in in vivo telomere 
maintenance.  Specifically, such findings could indicate that this region is necessary for 
the protein’s tertiary structure and a broad function within the holoenzyme.  For instance, 
Est1p may induce a conformational change or stabilize overall architecture of the 
complex via several interactions with other components of telomerase, minimally 
including TLC1 and Est3p and possibly Est2p.   
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Conservation of telomerase from yeast to humans 
 As with all basic science research, findings of this study must be considered in the 
context of human telomere maintenance.  While connections between different model 
systems can be quite obvious, potential correlations between S. cerevisiae and H. sapiens 
telomerase protein interactions are less clearly defined due to substantial divergence 
between these two species, especially in the case of the Est1 and Est3 proteins.     
 Humans have three EST1 proteins with similar sequence and domain structures as 
ScEst1p35,54,55.  Human EST1A and EST1B have been shown to associate with 
telomerase.  hEST1A also has a single-stranded DNA binding activity and plays a role in 
telomere capping90.  The functions of hEST1B and hEST1C have not been characterized 
to date.  One feature that the human EST1 proteins and S. cerevisiae Est1p have in 
common is a tetratricopeptide repeat (TPR) domain in the N terminus of the 
protein35,54,55.  TPR domains are most often implicated in protein-protein interactions, and 
it was very recently published that hEST1A interacts with the reverse transcriptase of 
human telomerase (hTERT) in vitro via its TPR domain91.  Intriguingly, the residue of 
ScEst1p required for interaction with Cdc13p lies outside the TPR domain, contrary to 
what may be expected considering the main function of tetratricopeptide repeats in the 
majority of other proteins.  And based on the position of Est1p’s putative Est3p 
recruitment domain, any amino acids with a contribution to this stimulatory function of 
Est1p will also lie outside the TPR domain. 
 These observations call into question the purpose of the TPR domain in ScEst1p.  
With little data examining potential functions of this region, one possibility is that Est1p 
interacts with an as-of-yet unidentified partner, likely another protein, via its TPR 
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domain.  Evidence supporting this speculation showed that mutations in the Est1p TPR 
domain disrupted the interaction of Est1 and Ies3 proteins as assessed by yeast 2-hybrid 
and immunoprecipitation46.  This partner may regulate Est1p’s actions in telomere 
maintenance, such as restricting its association with the holoenzyme for proper timing of 
telomere elongation or directing Est1p to short telomeres in need of elongation as a way 
to target telomerase to the correct substrates.  Considering other unpublished data from 
the Friedman lab, the TPR domain of Est1p may be partly responsible for nuclear 
localization of the protein by serving as a platform for interaction of Est1p with a 
component(s) of an import pathway, such as an importin.  Currently under examination is 
a bipartite nuclear localization sequence within the TPR domain that partially disrupts 
proper nuclear localization of Est1p when basic residues in the sequence are mutated to 
alanine (C. Hawkins and K. Friedman, in preparation), potential preliminary support for a 
specific role of Est1p’s TPR domain. 
 Similar to the S. cerevisiae proteins, human EST1 may not interact with its Est3p 
counterpart via the TPR domain, if these proteins interact at all.  The proposed 
homologue of ScEst3p is the oligonucleotide/oligosaccharide binding fold domain of the 
shelterin component TPP1, although the direct evolutionary relationship between these 
proteins is debatable92.  As a member of the shelterin complex, TPP1 functions in 
telomere capping by bridging double- and single-stranded DNA-binding proteins93.  
Since hEST1A has been shown to interact with hTERT91, it might be localized to the 
terminus of the telomere, similar to where S. cerevisiae Est1p and Est3p are predicted to 
associate.  However, having been shown genetically to affect telomere capping90, 
hEST1A may also be able to interact with TPP1 for this protective function, perhaps with 
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its localization regulated temporally, like the yeast Est1p.  Additionally, because so little 
is known about the human EST1B and EST1C proteins, further study of these 
homologues may reveal distribution of ScEst1p functions to the different human EST1 
proteins and potentially novel roles for conserved regions of Est1p in human telomere 
maintenance or other cellular pathways. 
 
Summary 
 In this study, I have shown that the region of Est1p between amino acids 499 and 
563 is important for stimulating the recruitment of Est3p to the yeast telomerase complex 
using an in vivo assembly assay.  Strains and plasmids for two genetic screens will yield 
tools for testing existing alleles for their role in Est3p recruitment and isolating new 
alleles of EST1 disrupted for this stimulatory function.  Proposed in vitro studies can be 
utilized to support findings from these in vivo experiments, potentially determine whether 
isolated alleles are true separation-of-function alleles, and probe interplay between 
Est1p’s various functions in the cell.  These analyses will provide insight into the 
mechanism of recruitment of the Est3 protein to the holoenzyme and thereby clarify the 
role of Est1p in regulating complex assembly, a debated topic in the field of yeast 
telomerase.  Additionally, understanding of S. cerevisiae telomerase components’ 
functions, interactions, and regulation can provide a basis for pursuing examination of 
human telomerase and potentially effect change in the treatment of certain disease states. 
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APPENDIX  
 
PLASMID CONSTRUCTION: pKF600 SERIES 
 
 The Friedman lab has previously used two high copy number plasmids containing 
EST1 under control of the GAL1 promoter.  The first of these plasmids, pRS423 GALp-
HA3-EST1, produced Est1p that is subjected to the normal cell cycle regulated 
degradation of the WT protein (J. Ferguson, unpublished data).  The second plasmid, 
pVL242 RA, does not have restriction sites for easily cloning other alleles of EST1 into 
this plasmid.  Therefore, with the guidance of fellow graduate student Jenifer Ferguson, I 
pieced together a high copy number plasmid containing galactose-inducible EST1 and 
convenient restriction sites.   
To begin, the SphI restriction site in pVL242 RA was destroyed by digesting 
with SphI, blunting with T4 DNA polymerase (NEB), and ligating the ends together.  The 
GAL promoter was amplified with primers 242bgl2for and 242bamhIrev and the EST1 N-
terminus was amplified using primers 242bamhIfor and E1DB3RtoKrev (both using 
pVL242 RA as template).  These products were then amplified as a single GALp-HA3-
EST1Nterm product using 242bgl2for and E1DB3RtoKrev.  The end result was the creation 
of a unique BamHI restriction site immediately upstream of the START codon of the 
EST1 open reading frame (ORF).  The GAL promoter was cloned from pVL242 RA 
into pRS416 with EcoRI and BamHI.  The EST1 ORF was amplified using the primer 
pair Gal1-2for (OP7753) and 242sphI/sacIrev from pVL242 RA.  The latter of these 
primers introduced an SphI restriction site at the end of the open reading frame and a SacI 
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site further downstream.  This PCR product was cloned into pRS416 GALp using BamHI 
and SacI.  The GALp-HA3-EST1Nterm PCR product was digested with BglI and PflmI and 
cloned into the BamHI and PflmI sites of pRS416 GALp-HA3-EST1, making pRS416 
GALp-HA3-EST1 fixed BamHI.  Inserting the PCR product into this vector moved the 
BamHI site immediately upstream of EST1 and destroyed the upstream BamHI site.  
PvuII was then used to move GALp-HA3-EST1 from the pRS416 vector to the pRS425 
vector backbone.  Next, a portion of EST1 was replaced with sequence that had not been 
PCR-amplified by digesting pVL242 RA with NdeI and NruI and cloning that portion 
into pRS425 GALp-HA3-EST1.  Finally, the EST1 termination sequence was amplified 
from pVL242 RA with the primers 423terminatorFor and 423terminatorRev and 
cloned into pRS425 GALp-HA3-EST1 using SacI.  This plasmid, pRS425 GALp-HA3-
EST1 + terminator, was sequenced with M516, E1DB3RtoKrev, E1DB2RtoKrev, and 
M13F before being renamed as pKF600. 
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Table A1. Oligonucleotide primers 
 
 
Table A2.  Plasmids 
 
Plasmid Genotype Source 
pRS416 CEN URA3 T. Graham 
pRS423 GAL-HA3-EST1 2µm HIS3 GALp-HA3-EST1 A. Sathiyakumar 
pRS425 2µm LEU2 T. Graham 
pKF600 2µm LEU2 GALp-HA3-EST1 This study 
pVL242 RA 2µm LEU2 GALp-HA3-EST1 
(RxxLxxxN to AxxLxxxN in linker 
between HA3 and EST1) 
J. Talley 
 
Primer name Primer sequence 5´-3´ 
242 bgl2 for GAGAAAAAACCCCAGATCTATGTACCCGTATG 
242 bamHI rev CTTCGTTATCCATTAGGATCCCATTTTTAAGCTTGG 
242 bamHI for CCAAGCTTAAAAATGGGATCCTAATGGATAACGAAG 
Gal1-2 For (OP7753) CGGTTTGTATTACTTCTTATTC 
242 sphI/sacI rev GCGCGAGCTCGCATGCTCAAGTAGGAGTATCTGGC 
423 terminator for GCATGCGAGCTCGAGAACAAGTAATGG 
423 terminator rev GCGCGAGCTCCTGCAGGTCG 
Est1 sequencing forward 
3 (M516) 
TTCTTGCATTAACTTTGC 
E1DB3RtoK rev CTAATGCTCCTTTTACGAGCTCAAAAAAATACAG 
E1DB2RtoK rev CCAGGAAGCATTTAAACGTGATATATGC 
M13F (-47) CGCCAGGGTTTTCCCAGTCACGAC 
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